Macquarie Group Portfolio holdings
AUM
$81.5B
1-Year Return
21.2%
This Quarter Return
+10.74%
1 Year Return
+21.2%
3 Year Return
+85%
5 Year Return
+166.7%
10 Year Return
+339.95%
AUM
$84.7B
AUM Growth
+$3.15B
(+3.9%)
Cap. Flow
-$3.42B
Cap. Flow
% of AUM
-4.04%
Top 10 Holdings %
Top 10 Hldgs %
10.93%
Holding
2,551
New
35
Increased
617
Reduced
853
Closed
517
Top Buys
| 1 |
L3Harris
LHX
|
+$119M |
| 2 |
Danaher
DHR
|
+$116M |
| 3 |
Zebra Technologies
ZBRA
|
+$111M |
| 4 |
West Pharmaceutical
WST
|
+$87.2M |
| 5 |
Assurant
AIZ
|
+$87M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$196M |
| 2 |
Microsoft
MSFT
|
+$189M |
| 3 |
Merck
MRK
|
+$147M |
| 4 |
Mastercard
MA
|
+$130M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$124M |
Sector Composition
| 1 | Technology | 21.39% |
| 2 | Healthcare | 15.17% |
| 3 | Financials | 13.51% |
| 4 | Industrials | 10.72% |
| 5 | Consumer Discretionary | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Arrowhead Research
ARWR
$4.11B
| $13K | ﹤0.01% |
325
-1,562
| -83% | -$62.5K |
|
1652
HSBC
HSBC
$239B
| $13K | ﹤0.01% |
405
+17
| +4% | +$546 |
|
1653
SAP
SAP
$301B
| $13K | ﹤0.01% |
124
-17
| -12% | -$1.78K |
|
|
CLVS
1654
DELISTED
Clovis Oncology, Inc.
CLVS
| $13K | ﹤0.01% |
250,200
| – | – |
|
|
TWOU
1655
DELISTED
2U, Inc.
TWOU
| $12.1K | ﹤0.01% |
65
-36
| -36% | -$6.73K |
|
1656
Banco Bilbao Vizcaya Argentaria
BBVA
$110B
| $12K | ﹤0.01% |
2,037
+98
| +5% | +$577 |
|
1657
Franco-Nevada
FNV
$38.9B
| $11K | ﹤0.01% |
+77
| New | +$11K |
|
1658
Prudential
PUK
$35.8B
| $11K | ﹤0.01% |
401
+30
| +8% | +$823 |
|
1659
Suncor Energy
SU
$51B
| $11K | ﹤0.01% |
360
-35
| -9% | -$1.07K |
|
1660
Embecta
EMBC
$895M
| $10.3K | ﹤0.01% |
410
+42
| +11% | +$1.06K |
|
1661
Shoe Carnival
SCVL
$651M
| $10K | ﹤0.01% |
400
| – | – |
|
|
ATNX
1662
DELISTED
Athenex, Inc. Common Stock
ATNX
| $10K | ﹤0.01% |
3,500
| – | – |
|
|
GMVD
1663
DELISTED
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
| $9.51K | ﹤0.01% |
2,925
+1
| +0% | +$3 |
|
1664
Liberty Broadband Class A
LBRDA
$8.68B
| $9.41K | ﹤0.01% |
124
| – | – |
|
1665
American Vanguard Corp
AVD
$159M
| $8K | ﹤0.01% |
389
| – | – |
|
1666
ING
ING
$73.9B
| $8K | ﹤0.01% |
671
+29
| +5% | +$346 |
|
1667
ORIX
IX
$30.2B
| $8K | ﹤0.01% |
490
+20
| +4% | +$327 |
|
1668
Unilever
UL
$156B
| $8K | ﹤0.01% |
149
+50
| +51% | +$2.69K |
|
1669
Diageo
DEO
$57.6B
| $7K | ﹤0.01% |
42
+3
| +8% | +$500 |
|
1670
Haleon
HLN
$44.2B
| $7K | ﹤0.01% |
833
-212,831
| -100% | -$1.79M |
|
1671
Kyndryl
KD
$7.57B
| $7K | ﹤0.01% |
656
-7,466
| -92% | -$79.7K |
|
|
CINC
1672
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $7K | ﹤0.01% |
609
| – | – |
|
1673
Kura Oncology
KURA
$766M
| $6K | ﹤0.01% |
469
-517
| -52% | -$6.61K |
|
1674
Smith & Nephew
SNN
$16.7B
| $6K | ﹤0.01% |
228
| – | – |
|
1675
Novo Nordisk
NVO
$241B
| $4K | ﹤0.01% |
56
-78
| -58% | -$5.57K |
|